GSK plc (GSK,GSK.L) announced the Japanese Ministry of Health, Labour and Welfare has granted SENKU designation for bepirovirsen, an investigational antisense oligonucleotide for the treatment of chronic hepatitis B. The company noted that the designation expedites review of bepirovirsen as a potential treatment for people living with chronic hepatitis B.
The designation is based on results from the phase IIb B-Clear and B-Sure trials which evaluated the efficacy, safety and durability of response of bepirovirsen in people with CHB. A confirmatory phase III programme is ongoing.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.